Skip to main content
. 2017 Aug 3;8:91–99. doi: 10.2147/LCTT.S138887

Table 5.

Multivariate analysis of overall survival

Covariate HR 95% Cl p-value
NDRF0 vs NDRF2 or 3 1.579 1.118–2.334 0.0013*
Age, ≤70 y vs ≥71 y 0.914 0.632–1.315 0.3146
Female vs. male 0.529 0.375–0.812 0.0011*
Non smokers vs smoker 1.028 0.679–1.536 0.7649
ECOG PS 0–2 vs. 3–4 0.374 0.217–0.534 <0.0001*
Non-sq vs. sq 0.593 0.296–0.975 0.0039*
Stage IIIb vs IV 0.582 0.413–0.872 0.0416*

Notes:

*

p<0.05. NDRF0: no high level of above markers; NDRF2: no fewer than two high levels of above markers; NDRF3: all high levels of above markers.

Abbreviations: NDRF, newly designed risk factor; ECOG, Eastern Cooperative Oncology Group; PS, performance status; sq, squamous cell carcinoma; HR, hazard ratio; CI, confidence interval.